suppl_file.pdf (59.18 kB)
Download fileSupplementary Figure 1. Substantial remission of Prostate Adenocarcinoma with Dendritic Cell therapy APCEDEN® in combination with chemotherapy
figure
posted on 31.10.2019, 16:14 by Chaitanya Kumar Thota, Jasmine Bagga, Srikanth Chiliveru, Sakshi Kohli, Asmi Bharadwaj, Minish Jain, Shriram Inamdar, Bandana SharanSupplementary Figure 1. Substantial remission of Prostate Adenocarcinoma with Dendritic Cell therapy APCEDEN® in combination with chemotherapy
Phenotypic assessment of dendritic cells before packaging of six doses of APCEDEN® treatment.
History
Usage metrics
Read the peer-reviewed publication
Categories
Keywords
Prostate adenocarcinomaImmunotherapyAPCEDEN®Dendritic cellsinterferon gammaIFNγNeutrophil lymphocyte ratioNLRPlatelet lymphocyte ratioPLRTregRegulatory T CellsNephrology and UrologyApplied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)Cancer Therapy (excl. Chemotherapy and Radiation Therapy)